LIXTE Biotechnology Holdings Appoints Two New Board Members and New Chief Financial Officer

Peter Stazzone Chief Financial Officer, LIXTE Biotechnology Holdings Lourdes Felix Board of Directors, LIXTE Biotechnology Holdings Guy Primus Board of Directors, LIXTE Biotechnology Holdings -- Company Relocates Corporate Headquarters to Boca Raton -- Boca Raton, Fla., Sept. 03, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT and LIXTW), a clinical-stage pharmaceutical company developing a new class of cancer therapy to enhance chemotherapy a ...